Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Filings indexed 1,562 across all filing types
Latest filing 2023-06-29 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1760

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
公告本公司現金股利發放公告
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement (888 characters) from a company regarding the distribution of cash dividends, including details such as dividend amounts, ex-dividend date, record date, and payment date. It does not contain financial statements or detailed financial analysis but is clearly an announcement about dividend payment. According to the filing definitions, announcements about dividend amounts and payment details fall under 'Notice of Dividend Amount (DIV)'. The document is not a full report but a specific dividend announcement.
2023-06-29 Chinese
本公司112年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a brief announcement from a company (1760 寶齡富錦) regarding the important resolutions passed at its Annual General Meeting (AGM) held on 112/06/29 (Taiwan calendar year). It lists key decisions such as approval of the 111年度盈餘分配案 (earnings distribution for the previous year), approval of the business report and financial statements, and notes no amendments to the articles or board elections. The document is short (643 characters) and primarily reports the results of the shareholder meeting resolutions. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. It is not the full AGM materials or presentations (AGM-R), nor a full annual report (10-K). Therefore, the correct classification is DVA with high confidence.
2023-06-29 Chinese
111年企業ESG資訊揭露
Environmental & Social Information Classification · 95% confidence The document contains detailed data on environmental, social, and governance (ESG) metrics such as greenhouse gas emissions, water usage, waste management, employee welfare, gender diversity in management, and board composition. These topics align with Environmental & Social Information reports, which focus on ESG performance. The document length is 1725 characters, which is consistent with a concise ESG report rather than a full annual or interim financial report. There is no indication of financial statements or earnings data, nor is there any mention of regulatory filings, voting results, or management changes. Therefore, the document is best classified as an Environmental & Social Information report.
2023-06-28 Chinese
112年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing data on fund loans and guarantee information for the current and previous month, including limits and balances. It is very short (622 characters) and contains tabular financial data but no comprehensive financial statements or detailed analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It is more of a regulatory disclosure or compliance update related to financial guarantees and loans. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-08 Chinese
112年5月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary revenue report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards (IFRS) and reporting requirements. The document is very short (778 characters) and does not contain detailed financial statements or management discussion. It is a regulatory disclosure of financial data but not a full financial report like an Annual Report or Interim Report. It is not an announcement of a meeting, voting results, or management changes. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of a full report.
2023-06-08 Chinese
112年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication that this is a full financial report, earnings release, or other types of filings. The document length is about 14,692 characters, which is consistent with a detailed insider shareholding disclosure. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2023-06-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.